GB0206993D0 - Susceptibility gene for inflammatory bowel disease - Google Patents

Susceptibility gene for inflammatory bowel disease

Info

Publication number: GB0206993D0
Authority: GB; United Kingdom
Prior art keywords: inflammatory bowel; bowel disease; susceptibility gene; susceptibility; gene
Prior art date: 1999-09-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

GBGB0206993.8A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Oxford University Innovation Ltd

Original Assignee

Oxford University Innovation Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-23

Filing date

1999-09-23

Publication date

2002-05-08

1999-09-23 Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd

2002-05-08 Publication of GB0206993D0 publication Critical patent/GB0206993D0/en

2002-07-31 Publication of GB2371622A publication Critical patent/GB2371622A/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Analytical Chemistry (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

GB0206993A 1999-09-23 1999-09-23 Susceptibility gene for inflammatory bowel disease Withdrawn GB2371622A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/GB1999/003192 WO2001021832A1 (en)	1999-09-23	1999-09-23	Susceptibility gene for inflammatory bowel disease

Publications (2)

Publication Number	Publication Date
GB0206993D0 true GB0206993D0 (en)	2002-05-08
GB2371622A GB2371622A (en)	2002-07-31

Family

ID=10847634

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0206993A Withdrawn GB2371622A (en)	1999-09-23	1999-09-23	Susceptibility gene for inflammatory bowel disease

Country Status (4)

Country	Link
AU (1)	AU6104699A (en)
CA (1)	CA2385381A1 (en)
GB (1)	GB2371622A (en)
WO (1)	WO2001021832A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101943311B (en) *	2010-08-23	2012-12-26	广东爵仕泳池水疗设备有限公司	Multifunctional TV mount
RU2563172C1 (en) *	2014-11-12	2015-09-20	Общество с ограниченной ответственностью "Покровский банк стволовых клеток"	METHOD FOR DETERMINING CCR5 delta 32 ALLELE POLYMORPHISM

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69731373T2 (en) *	1996-03-01	2006-03-09	Euroscreen S.A.	CC CHEMOKIN CECTOR C-C CKR-5, DERIVATIVES AND USES THEREOF
WO1998005798A1 (en) *	1996-08-08	1998-02-12	The Aaron Diamond Aids Research Center	Hiv coreceptor mutants
WO1998034945A1 (en) *	1997-02-06	1998-08-13	Epoch Pharmaceuticals, Inc.	Targeted modification of the ccr-5 gene
KR20010032841A (en) *	1997-12-19	2001-04-25	다케다 야쿠힌 고교 가부시키가이샤	Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative

1999
- 1999-09-23 AU AU61046/99A patent/AU6104699A/en not_active Abandoned
- 1999-09-23 WO PCT/GB1999/003192 patent/WO2001021832A1/en active Application Filing
- 1999-09-23 GB GB0206993A patent/GB2371622A/en not_active Withdrawn
- 1999-09-23 CA CA002385381A patent/CA2385381A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU6104699A (en)	2001-04-24
CA2385381A1 (en)	2001-03-29
WO2001021832A1 (en)	2001-03-29
GB2371622A (en)	2002-07-31

Publication	Publication Date	Title
HUP0303622A3 (en)	2008-11-28	Emedies for inflammatory bowel diseases
AU2002232222A1 (en)	2003-03-27	Therapeutic Agents for Inflammatory Bowel Diseases
IL143936A0 (en)	2002-04-21	Gene expression profiling of inflammatory bowel disease
GB9925459D0 (en)	1999-12-29	Gene silencing
HUP0201438A3 (en)	2004-07-28	Dna vaccine - pcv
AU2446801A (en)	2001-07-03	Treatment for inflammatory bowel disease (ibd) and related conditions
GB9904991D0 (en)	1999-04-28	Genetic screening
EP1142591A4 (en)	2002-03-06	GENE SUPPORTS
HUP0105208A3 (en)	2004-08-30	Gene therapy-1
IL149599A0 (en)	2002-11-10	Use of disease-associated gene
GB0124315D0 (en)	2001-11-28	Inflammatory bowel disease
IL146332A0 (en)	2002-07-25	PrP-LIKE GENE
EP1444983A4 (en)	2006-11-08	Agents for treating inflammatory bowel diseases
GB0206993D0 (en)	2002-05-08	Susceptibility gene for inflammatory bowel disease
AU1917301A (en)	2001-05-30	Aryl nitrone therapeutics and methods for treating inflammatory bowel disease
EP1215284A4 (en)	2004-05-19	Tsg-like gene
GB0000563D0 (en)	2000-03-01	Susceptibility gene for autoimmune disease
GB9905644D0 (en)	1999-05-05	Dna
IL137292A0 (en)	2001-07-24	Biological models exhibiting secondary disease manifestations
EP1176198A4 (en)	2002-10-30	Novel fetal genes
GB9925491D0 (en)	1999-12-29	Genetic biosensors using chemiluminescence
GB9921544D0 (en)	1999-11-17	Genetic testing
GB9924078D0 (en)	1999-12-15	Genetic testing
GB9915978D0 (en)	1999-09-08	Genetic testing
GB9922984D0 (en)	1999-12-01	Genetic testing

Legal Events

Date	Code	Title	Description
2004-10-20	WAP	Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)